BCLA CLEAR Presbyopia: Epidemiology and impact.

Himal Kandel, Maria Markoulli, Kevin D Frick, James S Wolffsohn, Timothy R Fricke, Anitha Arvind, Kerryn M Hart, Mahesh R Joshi, Antonio Filipe Macedo, Dimitra Makrynioti, Neil Retallic, Nery Garcia-Porta, Gauri Shrestha

Journal: Contact lens & anterior eye : the journal of the British Contact Lens Association 2024;47(4):102157

PMID: 38594155

Abstract

The global all-ages prevalence of epidemiologically-measured 'functional' presbyopia was estimated at 24.9% in 2015, affecting 1.8 billion people. This prevalence was projected to stabilise at 24.1% in 2030 due to increasing myopia, but to affect more people (2.1 billion) due to population dynamics. Factors affecting the prevalence of presbyopia include age, geographic location, urban versus rural location, sex, and, to a lesser extent, socioeconomic status, literacy and education, health literacy and inequality. Risk factors for early onset of presbyopia included environmental factors, nutrition, near demands, refractive error, accommodative dysfunction, medications, certain health conditions and sleep. Presbyopia was found to impact on quality-of-life, in particular quality of vision, labour force participation, work productivity and financial burden, mental health, social wellbeing and physical health. Current understanding makes it clear that presbyopia is a very common age-related condition that has significant impacts on both patient-reported outcome measures and economics. However, there are complexities in defining presbyopia for epidemiological and impact studies. Standardisation of definitions will assist future synthesis, pattern analysis and sense-making between studies.

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Address: School of Optometry and Vision Science, UNSW Sydney, Australia. Electronic address: [email protected].; School of Optometry and Vision Science, UNSW Sydney, Australia; Department of Optometry and Vision Science, University of Melbourne, Australia; National Vision Research Institute, Australian College of Optometry, Melbourne, Australia.; Department of Optometry, School of Medical and Allied Sciences, GD Goenka University, India.; Johns Hopkins Carey Business School, USA; Johns Hopkins Bloomberg School of Public Health Departments of International Health and Health Policy and Management, USA; Johns Hopkins School of Medicine, Department of Ophthalmology, USA.; School of Medicine, Faculty of Health, Deakin University, Australia; Member Support and Optometry Advancement, Optometry Australia, Australia.; School of Health Professions, University of Plymouth, United Kingdom.; Save Sight Institute, Faculty of Medicine and Health, The University of Sydney, Australia; Sydney Eye Hospital, Australia.; Department of Medicine and Optometry, Faculty of Health and Life Sciences, Linnaeus University, Sweden; Centre of Physics of Minho and Porto Universities, School of Sciences, University of Minho, Braga, Portugal.; School of Health Rehabilitation Sciences, University of Patras, Greece.; Specsavers Optical Group, La Villiaze, St. Andrew's, Guernsey, United Kingdom; School of Optometry and Vision Science, University of Bradford, Bradford, United Kingdom.; Applied Physics Department, Optics and Optometry Faculty, University of Santiago de Compostela, Spain; Institute of Materials (iMATUS) of the University of Santiago de Compostela, Spain.; Optometry Department, BPK Centre for Ophthalmic Studies, Institute of Medicine, Nepal.; School of Optometry, Health and Life Sciences, Aston University, Birmingham, United Kingdom.

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.